Patents and Trademarks
Exiqon, AQ-Link, LNA, miRCURY, Hy3, Hy5, miRPlus, ProbeLibrary, ProbeFinder and Genoview are registered trademarks of Exiqon A/S, Vedbaek, Denmark.
Cy® is a registered trademark of Amersham Biosciences (GE Healthcare). FAM™, HEX™, ROX™ and TAMRA™ are trademarks of Applied Biosystems, Inc. , TEX™ and TYE™ are trademarks of Integrated DNA Technologies, Inc. , Texas Red®is a trademark of Molecular Probes Inc. (Life Technologies Corporation).
RNAlater™ is a registered trademark of Ambion Inc. Biomek™ 3000 is a registered trademark of Beckman Coulter Inc. epMotion™ is a registered trademark of Eppendorf AG. SYBRTM and Lipofectamine™ 2000 are registered trademarks of Invitrogen Inc. Nucleofector™ II Device is a registered trademark of Lonza Cologne AG. LightCycler™, and X-tremeGENE™ are registered trademarks of Roche Diagnostics GmbH. Tecan HS 4800™ Pro is a registered trademark of Tecan Trading AG and NanoDrop™ is a registered trademark of Thermo Fisher Scientific Inc.
Anthraquinone photochemistry products (AQ products) are covered by patents controlled by Exiqon A/S. Locked Nucleic Acids (LNA™) are covered by patents and patent applications owned by Exiqon A/S.
SYBR® is a registered trademark of Invitrogen. ABI® is a registered trademark of Applied Biosystems. StepOnePlus™ and ViiA™ are trademarks of Applied Biosystems. Bio-Rad® and iCycler® are registered trademarks of Bio-Rad Laboratories, Inc. Chromo4™, iQ™4, iQ™5, and MyiQ™ are trademarks of Bio-Rad Laboratories, Inc. LightCycler® is a registered trademarks of Roche Molecular Systems. Mastercycler® is a registered trademark of Eppendorf. Mx3005p™, Mx3000p™, and Mx4000™ are trademarks of Stratagene.
Products are for research use only and not for diagnostic or therapeutic use. The products may be used only for the buyer's internal research purposes and not for commercial use. The buyer may not resell products in their original or any modified form. The purchase of products does not include or carry an implied right or license for the buyer to use such products in the provision of services to third parties and a license must be obtained directly from Exiqon A/S for such use. Prespotted arrays
This product and its use are covered by one or more of the following patents owned by Oxford Gene Technology Limited or Oxford Gene Technology IP Limited: US 6,054,270, US 5,700,637, EP 0,373,203; Jap. 3,393, 528 and 3,386,391 and pending patents. The purchaser is licensed to practice methods and processes covered by these patents using this product for its own internal research purposes only but may not: transfer data derived from the use of this product to third parties for value; use this product in the provision of services to third parties for value; use this product to make, have made, create or contribute to the creation of stand alone expression database products for license, sale or other transfer to a third party for value; or use this product for the identification of antisense reagents or the empirical design of probes or sets of probes for using or making nucleic acid arrays. Capture probe oligonucleotide sets
Exiqon A/S is not licensed under any patents owned by Oxford Gene Technology Limited or related companies (»OGT«) and cannot pass any such license to its customers. A license under OGT's patents may be necessary to manufacture or use oligonucleotide arrays. To enquire about a license under OGT's oligonucleotide array patents, please contact email@example.com. PCR system
Purchase of the products includes an immunity from suit under patents specified in the product insert to use only the amount purchased for the purchaser’s own internal research. No other patent rights are conveyed expressly, by implication, or by estoppel. Further information on purchasing licenses may be obtained by contracting the Director of Licensing Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA. The products are provided under an agreement between Molecular Probes, Inc., a wholly owned subsidiary of Invitrogen Corporation, and EXIQON and the manufacture, use, sale or import of this product is subject to one or more U.S. Patents and corresponding international equivalents. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product in research conducted by the buyer, where such research does not include testing, analysis or screening services for any third party in return for compensation on a per test basis. The buyer cannot sell or otherwise transfer (a) this product (b) its components or (c) materials made using this product or its components to a third party or otherwise use this product or its components or materials made using this product or its components for Commercial Purposes. Commercial Purposes means any activity by a party for consideration and may include, but is not limited to: (1) use of the product or its components in manufacturing; (2) use of the product or its components to provide a service, information, or data; (3) use of the product or its components for therapeutic, diagnostic or prophylactic purposes; or (4) resale of the product or its components, whether or not such product or its components are resold for use in research. For information on purchasing a license to this product for purposes other than research, contact Molecular Probes, Inc., Business Development, 29851 Willow Creek Road, Eugene, OR 97402. Tel: (541) 465-8300, Fax: (541) 335-0354. Further, the purchase of this product includes a limited, non-transferable license under specific claims of U.S. Patent Nos. 6,174,670 and 6,569,627, owned by the University of Utah Research Foundation and licensed to Roche Diagnostics GmbH and Idaho Technology, Inc., to use only the enclosed amount of product according to the specified protocols. No right is conveyed, expressly, by implication, or by estoppel, to use any instrument or system under any claim of U.S. Patent Nos. 6,174,670 and 6,569,627, other than for the amount of product contained herein. PCR Primer Sets
No license is conveyed with the purchase of this product under any of US Patents Nos. 5,804,375, 5,994,056, 6,171,785, 5,538,848, 5,723,591, 5,876,930, 6,030,787, and 6,258,569, and corresponding patents outside the United States, or any other patents or patent applications, relating to the 5' Nuclease and dsDNA-Binding Dye Processes. For further information contact the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California 94404, USA. DIG
DIG is licensed from Roche Diagnostics GmbH. PCR Services
US: This test is performed pursuant to licensing arrangements with Roche Molecular Systems, Inc. and Applera Corporation. DK: This test is performed pursuant to licensing arrangements with F. Hoffman-La Roche Ltd and Applera Corporation. NOTE reg. commercial use.: Certain aspects of allele-specific PCR and or SNP detection are covered by patents owned by Hoffmann la Roche, Mayo Foundation, Orchid Biosciences Inc, Affymetrix Inc, Stanford University, Exiqon A/S and others. Certain aspects of RNAi and siRNA are covered by patents owned by Carnegie Institution of Washington, Alnylam Europe Ag, Max Planck Gesellschaft, Santaris Pharma A/S, Integrated Dna Technologies Inc. and others. Certain aspects of Gapmers are covered by patents owned by Isis Pharmaceuticals Inc, University of Texas and others. DNAzymes are covered by patents owned by Ribozyme Pharmaceuticals Inc. Certain aspects of the use of LNA for antisense inhibition may be covered by patents and patent-applications controlled by Santaris Pharma A/S or ISIS Pharmaceuticals, Inc. SNP genotyping may be covered by Genetic Technologies Limited (GTG) patents relating to allelic discrimination or SNP genotyping. Molecular beacons are covered by one or more patents owned by Caliper Technologies Corp, Zeneca Limited, Exiqon A/S, Cenetron Diagnostics Llc and others. Microarray may be covered by one or more patents owned by Oxford Gene Technology Limited or Oxford Gene or Affymetrix, Inc.
Specifications in this document are subject to change without notice.